Skip to content
Wenlo
Sign in
← Markets

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BMRN) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GBMRNFiled Nov 20, 2026, 2:07 PM ET

About this filing

BioMarin Pharmaceutical Inc. (BMRN) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 20, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

Key facts

Document
—

More BMRN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.